NCT00864305 - A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

January 31, 1998

Study Completion Date

January 31, 1998

Conditions

Healthy

Interventions

DRUG

Gabapentin 400 mg capsules

A: Experimental Subjects received Purepac formulated products under fed conditions

DRUG

NEURONTIN® 400 mg capsules

B: Active comparator Subjects received Parke-Davis's marketed product

DRUG

Gabapentin 400 mg capsules, single dose

C: Experimental Subjects received Purepac formulated products under fasting conditions

Trial Locations (1)

Gateway Medical Research, Inc, Saint Charles